As the holidays approach, be sure to check our seasonal shipping updates here! Happy Holidays!

Skip to content

Search for:

Products
CE-IVD Products
Automation Support
Applications
Support
Company
News
- News
- Events
Distributors

Search for:

Products
CE-IVD Products
Automation Support
Applications
Support
Company
News
- News
- Events
Distributors

Intrinsic Subtypes, PIK3CA Mutation, and the Degree of Benefit From Adjuvant Trastuzumab in the NSABP B-31 Trial

Download

File Type: 2439

Categories: Peer Reviewed

Tags: M6958

← Previous Document

Next Document →

Shopping Cart

Omega Bio-tek, Inc.
400 Pinnacle Way, Suite 450
Norcross, Georgia 30071
P: 770.931.8400
F: 770.931.0230
H: Mon - Fri, 8 AM - 5 PM ET
E: info@omegabiotek.com

Terms and conditions
Privacy Policy
Support
Distributors
Minority Supplier Certification

Copyright © 2025 Omega Bio-tek, Inc. ISO 9001:2015 | ISO 13485:2016

Scroll to Top

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.